Mineko Tominaga
Federal University of São Paulo
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mineko Tominaga.
Chemistry Letters | 1993
Yeondae Kwon; Ruoheng Zhang; Marcelo P. Bemquerer; Mineko Tominaga; Hironobu Hojo; Saburo Aimoto
Methods for the preparation of partially-protected cysteine-containing peptide segments were developed. The peptide thioester, obtained via a solid-phase method of Boc chemistry, was used for segment condensation with an amino component peptide in the presence of silver ions and N-hydroxysuccinimide to give a desired product in good yield.
Archive | 2002
Guita N. Jubilut; Antonio Miranda; Eliandre de Oliveira; Eduardo Maffud Cilli; Mineko Tominaga; Clovis R. Nakaie
For decades, the propionic acid/12 N HCl (1:1, v/v) mixture at 130 °C [1] or 160 °C [2] has been used as the standard solution for aminoacylor peptidyl-resin hydrolysis. However, no further systematic study has been carried out concerning the applicability of this hydrolysis protocol to other resins introduced later in the SPPS field. In this regard, we have recently demonstrated that much longer hydrolysis time than reported in the literature is necessary for quantitative cleavage of aminoacylor peptidyl-groups from most resins used in the Boc-strategy [3]. The hydrolysis times necessary for complete cleavage of Phe resin are 100 h (at 130 °C) or 30 h (at 160 °C) for benzhydrylamine-resin (BHAR) and 30 h (at 130 °C) or 18 h (at 160 °C) for p-methyl-benzhydrylamine(MBHAR) and 4(oxymethyl)-phenylacetamidomethyl-resin (PAMR). In order to propose a more accelerated hydrolysis protocol, the present report describes a comparative time-course hydrolysis study of aminoacyland dipeptidyl-resins using a trifluoroacetic acid (TFA)/12 N HCl hydrolysis mixture in different proportions. The Gly and Phe residues and the corresponding dipeptide sequences (Ala-Gly and Ala-Phe) coupled to PAMR, BHAR, MBHAR and also to chloromethyl-resin (CMR) were studied as models for this alternative hydrolysis condition at 160 °C.
Archive | 1999
Eliandre de Oliveira; A. Miaranda; David Andreu; Shirley Schreier; Antonio C. M. Paiva; Clovis R. Nakaie; Mineko Tominaga
In a recent paper [1], we investigated alternative strategies to minimize difficulties in synthesizing and purifying a long and hydrophobic transmembrane peptide sequence (Ac-CTVAEIYLGNLAGADLILASGLPFWAITANNFDNH2 , denoted TM2-34) corresponding to the (64–97) region of the second transmembrane segment of the rat BKB2 receptor [2]. Improved yield of synthesis was obtained by changing the solvent system during the coupling step, accordingly to our conjugated resin solvation-polarity of the medium strategy [3]. We also performed a preliminary conformational analysis of this 34-mer peptide and its minor fragment (74–94), denoted TM2-24, by circular dichroism (CD) in aqueous solution containing different amounts of hexafluoroisopropanol (HFIP). In this solvent, a well-known α-helical structure inducer, we have found a α-helical content lower than expected for this type of transmembrane fragment. Hence, to better investigate structural properties of these two peptides, taken as model of transmembrane fragment, CD and fluorescence spectroscopic methods were applied in aqueous solution, varying the pH and the proportion of trifluoroethanol (TFE), and an other secondary structure inducing solvent. This structural investigation was also carried out in presence of dodecylsulp h a t e ( S D S ) a n d N -hexadecyl-N,N,dimethyl-3-ammonium-1 propylsulphate(HPS)-type micelles. Owing to the low solubility of TM2-34 analog, most of experiments in aqueous solution were performed with the TM2-24 transmembrane fragment.
Journal of Medicinal Chemistry | 1970
Therezinha B. Paiva; Mineko Tominaga; Antonio C. M. Paiva
European Journal of Organic Chemistry | 2002
Eliandre de Oliveira; Eduardo Maffud Cilli; Antonio Miranda; Guita N. Jubilut; Fernando Albericio; David Andreu; Antonio C. M. Paiva; Shirley Schreier; Mineko Tominaga; Clovis R. Nakaie
Chemical & Pharmaceutical Bulletin | 2001
Mineko Tominaga; Simone R. Barbosa; Erick Fernando Poletti; Julio Zukerman-Schpector; Reinaldo Marchetto; Shirley Schreier; Antonio Cechelli Mattos Mattos Paiva; Clovis R. Nakaie
Chemical & Pharmaceutical Bulletin | 2001
Guita N. Jubilut; Eduardo Maffud Cilli; Mineko Tominaga; Antonio Miranda; Yoshio Okada; Clovis R. Nakaie
Journal of Medicinal Chemistry | 1977
Elisabeth B. Sabia; Mineko Tominaga; Antonio C. M. Paiva; Therezinha B. Paiva
ChemInform | 1975
Mineko Tominaga; John M. Stewart; Therezinha B. Paiva; Antonio C. M. Paiva
Journal of Peptide Research | 2009
Eliandre de Oliveira; Antonio Miranda; Fernando Albericio; David Andreu; Antonio C. M. Paiva; Clovis R. Nakaie; Mineko Tominaga